Stay updated on Pembrolizumab in Neoplasms Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Neoplasms Clinical Trial page.

Latest updates to the Pembrolizumab in Neoplasms Clinical Trial page
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe Publications description now says entries are automatically filled from PubMed and may not be about the study, and the page shows a revision note for v3.3.2.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the government funding lapse notice that previously appeared on the page. No other visible study details or navigation elements were altered.SummaryDifference0.4%

- Check49 days agoChange DetectedNo significant changes to core study information were detected; the updates appear to be formatting or copy edits rather than changes to eligibility, endpoints, or enrollment numbers. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check70 days agoChange DetectedAdded a government operating-status notice and updated the version to v3.2.0; removed the previous v3.1.0 version reference.SummaryDifference2%

- Check78 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0, indicating a newer release.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page update is a minor version bump from v3.0.1 to v3.0.2; a small 'Back to Top' element was removed, with no substantive content changes.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Neoplasms Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Neoplasms Clinical Trial page.